Finance

Beta
Lists
C1OO34:BVMF
Cooper Companies Inc Bdr
R$31.02
0.00%
(0.00) 1D
May 29, 12:17:25 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for C1OO34...
Mkt. cap
13.14B
Avg. vol.
3.00
Volume
0.00
52-wk high
R$47.00
52-wk low
R$29.00
Shares outstanding
195.11M
No. of employees
15K
Mkt. cap
13.14B
Avg. vol.
3.00
Volume
0.00
52-wk high
R$47.00
52-wk low
R$29.00
Shares outstanding
195.11M
No. of employees
15K
News stories
From sources across the web
Profile
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision which manufactures contact lenses, and CooperSurgical, which manufactures medical devices and fertility and genomic products for the women's healthcare market. Wikipedia
About Cooper Companies Inc Bdr
CEOAlbert G. White III
Employees15K
Founded1958
HeadquartersPleasanton, California, United States
SectorMedical device
Websitecoopercos.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
1.06B
1.07B
1.02B
1.08B
Cost of goods sold
368.30M
414.30M
328.90M
346.10M
Cost of revenue
368.30M
414.30M
328.90M
346.10M
Research and development expenses
44.60M
41.40M
44.30M
42.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
421.70M
415.40M
390.20M
676.20M
Operating expense
516.30M
506.60M
482.40M
766.40M
Total operating expenses
884.60M
920.90M
811.30M
1.11B
Operating income
175.70M
144.20M
212.80M
-31.00M
Other non operating income
3.10M
-16.40M
3.10M
3.50M
EBT including unusual items
151.90M
116.80M
192.20M
-48.40M
EBT excluding unusual items
151.90M
101.10M
192.20M
-48.40M
Income tax expense
53.60M
32.20M
61.40M
29.50M
Effective tax rate
35.29%
27.57%
31.95%
-60.95%
Other operating expenses
-
-
-
-
Net income
98.30M
84.60M
130.80M
-77.90M
Net profit margin
9.27%
7.94%
12.77%
-7.20%
Earnings per share
1.10
1.15
1.10
1.21
Interest and investment income
-
-
-
-
Interest expense
-25.40M
-24.40M
-22.40M
-20.90M
Net interest expenses
-25.40M
-24.40M
-22.40M
-20.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
271.10M
242.60M
308.30M
64.50M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer